Energous (NSDQ:WATT) announced today that its partner NewSound received FCC approval for its WattUp-enabled Primo W hearing aid. NewSound Primo W, a next-generation hearing aid, utilizes Energous’ WattUp radio frequency-based wireless charging technology, which supports small, rounded devices such as behind-the-ear and in-the-ear hearing aids, according to a news release. Along with hassle-free battery recharging, […]
Otolaryngology/Ear, Nose & Throat (ENT)
Eargo soars after announcing $141.3M IPO
Hearing device developer Eargo announced today that it priced its initial public offering of common stock at approximately $141.3 million. Beginning trading on the Nasdaq market today under the EAR ticker, shares were trading up 102.22% at $36.40 per share in late-afternoon trading. San Jose, Calif.-based Eargo is offering more than 7.85 million shares of its […]
Intersect ENT to acquire Fiagon for $71.1M
Intersect ENT (NSDQ:XENT) announced today that it entered into an agreement to acquire Fiagon AG Medical Technologies for $71.1 million. The $71.1 million (€60 million) cash deal will see Intersect ENT make an initial $17.8 million (€15 million) payment at the time of closing and further $17.8 (€15 million) annual payments over the following three years. […]
PhotoniCare raises more than $6M
Middle ear imaging technology developer PhotoniCare today filed an SEC Form D to confirm the sale of nearly $6.3 million in equity. Champaign, Ill.-based PhotoniCare, which made the first sale in the new notice offering on Aug. 25, 2020, does not intend for it to last longer than one year. It is not being made […]
Aerin Medical closes $48M financing, appoints new CEO
Aerin Medical announced today that it closed a $48 million equity financing and appointed Matt Brokaw as its new president & CEO. Brokaw previously served in roles at Tusker Medical, Spirox, Entellus Medical, Stryker (NYSE:SYK), Acclarent, Johnson & Johnson (NYSE:JNJ) and Smith & Nephew (NYSE:SNN). “Aerin is primed for its next phase of growth, propelled by non-invasive treatments […]
Irish medtech startup AventaMed brings on U.S.-based CEO
Traditional ear tube surgery alternative developer AventaMed announced that it appointed U.S.-based Keith Jansen as its new president & CEO. The Cork, Ireland-based medtech startup said in a news release that Jansen will succeed co-founder Olive O’Driscoll in the positions as he attempts to lead the company beyond its current startup phase and into the […]
Goggles could provide extra protection against coronavirus, Fauci says
Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci reportedly says goggles could further prevent the spread of COVID-19. Reports from ABC News say that Fauci told the outlet’s chief medical correspondent, Dr. Jennifer Ashton, on an Instagram Live conversation that Americans should consider wearing goggles or a face shield to protect […]
Eargo closes $71m financing
Hearing device developer Eargo announced today that it closed a $71 million equity financing as it looks to expand its commercialization efforts. New co-investors Gilde Healthcare and Longitude Capital led the investment, with existing investors New Enterprise Associates, the Charles and Helen Schwab Foundation and Nan Fung Life Sciences also participating. Gilde Healthcare’s Geoff Pardo […]
Report: Medtronic makes a bid for Intersect ENT
Intersect ENT (NSDQ:XENT) shares soared today on news that Medtronic (NYSE:MDT) has made a bid for the Menlo Park, Calif.-based ear, nose and throat condition treatment developer. Bloomberg reported the transaction late Tuesday, attributing the news to “people with knowledge of the matter.” Traders sent Intersect ENT shares up 38% in premarket trading. Medtronic declined to comment. […]
SpeechVive raises $1.5m for speech improvement device
SpeechVive announced today that it raised more than $1.5 million upon the completion of a convertible note as it looks to begin scaling its business. The West Lafayette, Ind.-based, Purdue University-affiliated medical device company develops treatments for speech conditions in people who suffer from chronic neurological diseases, such as Parkinson’s disease. SpeechVive’s device fits behind […]
FDA approves Cochlear sound processor
Cochlear Ltd. (ASX:COH) announced today that it received FDA approval for three new products in its suite of implantable hearing technology. Lone Tree, Colo.-based Cochlear won approval for its Nucleus Kanso 2 sound processor, Nucleus 7 sound processor for Nucleus 22 implant recipients and Custom Sound Pro fitting software, according to a news release. Cochlear touts […]
